People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.

The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in ...

The FDA has approved the use of Spravato, an antidepressant nasal spray, as a standalone treatment for depression in the U.S. Sue Varma discusses why she supports the use of the drug and how it may ...

Post-nasal drip occurs when mucus moves down your throat, causing irritation and cough. Here’s how medical professionals say ...

Nasal steroids provided the most significant benefit, especially when compared to montelukast. Nasal antihistamines also ...

An alternative, nasal spray, formulation has been developed that demonstrates good efficacy, high tolerability and a very fast onset of action. This study assessed the pharmacokinetics and ...

The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment ... plans and options to determine the best way to incorporate Spravato into their care ...

An ear, nose and throat doctor explains why tipping your head back with a nosebleed could make things worse and what you ...

The FDA's expanded approval will allow the drug to be more accessible with insurance. Parkside Psychiatric Hospital in Tulsa has an on-site Spravato outpatient clinic that sees over 20 patients ...

This nasal spray vaccine can be self-administered or given by a caregiver, potentially increasing vaccination rates and accessibility.